Abstract:The zebrafish (Danio rerio) has emerged as an appreciated and versatile model organism for studying cardiovascular and metabolic diseases, offering unique advantages for both basic research and drug discovery. The genetic conservation between zebrafish and humans and their high fecundity and transparent embryos allow for efficient large-scale genetic and drug-oriented screening studies. Zebrafish possess a simplified cardiovascular system that shares similarities with mammals, making them particularly suitable for modeling various aspects of heart development, function, and disease. The transparency of zebrafish embryos enables the real-time visualization of cardiovascular dynamics, offering insights into early embryonic events and facilitating the study of heart-related anomalies. In metabolic research, zebrafish provide a cost-effective platform for modeling obesity, type 2 diabetes, hyperlipidemia, and other metabolic disorders. Their high reproductive rate allows for the generation of large cohorts for robust statistical analyses, while advanced genetic tools, such as CRISPR/Cas9, enable precise gene editing with which to model specific genetic mutations associated with human diseases. Zebrafish metabolic models have been instrumental in elucidating the molecular mechanisms underlying metabolic diseases, studying the effects of environmental factors, and identifying potential therapeutic targets. Additionally, the permeability of zebrafish embryos to small molecules facilitates drug discovery and screening, offering a rapid and economical approach to identifying compounds with therapeutic potential. In conclusion, zebrafish cardiovascular and metabolic disease models continue to contribute significantly to our perception of disease pathogenesis, providing a platform for translational research and developing novel therapeutic interventions. The versatility, scalability, and genetic manipulability of zebrafish position them as an invaluable asset in unraveling the complexities of cardiovascular and metabolic diseases. This review presents an overview of the zebrafish model's key features and contributions to investigating cardiovascular and metabolic disorders. We discuss the benefits and drawbacks of using zebrafish models to study human disease and the critical findings revealed by the progress in this endeavor to date.

Zebrafish as a model organism for virus disease research: Current status and future directions

Zebrafish As a Model for Rhabdovirus Infection and Molecular Mechanism of the Immune Response

Application of the zebrafish model in human viral research

Zebrafish models of COVID-19

Zebrafish as a Model for Investigating Antiviral Innate Immunity

Zebrafish (Danio rerio) as a Model System to Investigate the Role of the Innate Immune Response in Human Infectious Diseases

Zebrafish As An Animal Model For The Antiviral Rna Interference Pathway

Zebrafish Infection: From Pathogenesis to Cell Biology

Zebrafish: An Emerging Model System for Human Disease and Drug Discovery

Animal models of human disease: zebrafish swim into view

The zebrafish as a potential model for vaccine and adjuvant development

Zebrafish as an animal model for biomedical research

Zebrafish as a Model for Cardiovascular and Metabolic Disease: The Future of Precision Medicine

Zebrafish and Medaka: new model organisms for modern biomedical research

Application of Zebrafish As Research Model in Immunology

For pet's sake: Discovering a naturally occurring zebrafish virus

Zebrafish as a Model Organism for Studying Pathologic Mechanisms of Neurodegenerative Diseases and other Neural Disorders

Zebrafish: An emerging model system to study liver diseases and related drug discovery

The potential of zebrafish as drug discovery research tool in immune-mediated inflammatory disease

Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens

Zebrafish as a model organism for neurodegenerative disease